NO20040312L - Fremgangsmåte for fremstilling av farmasøytiske preparater - Google Patents

Fremgangsmåte for fremstilling av farmasøytiske preparater

Info

Publication number
NO20040312L
NO20040312L NO20040312A NO20040312A NO20040312L NO 20040312 L NO20040312 L NO 20040312L NO 20040312 A NO20040312 A NO 20040312A NO 20040312 A NO20040312 A NO 20040312A NO 20040312 L NO20040312 L NO 20040312L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NO20040312A
Other languages
English (en)
Inventor
Thomas Rheinländer
Gül Caglar
Original Assignee
Institut Fuer Diagnostikforschung Gmbh An Der Freien Univ Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Fuer Diagnostikforschung Gmbh An Der Freien Univ Berlin filed Critical Institut Fuer Diagnostikforschung Gmbh An Der Freien Univ Berlin
Publication of NO20040312L publication Critical patent/NO20040312L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D57/00—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C
    • B01D57/02—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C by electrophoresis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/04—Processes using organic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/12—Ion-exchange processes in general; Apparatus therefor characterised by the use of ion-exchange material in the form of ribbons, filaments, fibres or sheets, e.g. membranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Electrochemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Acoustics & Sound (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20040312A 2001-07-26 2004-01-23 Fremgangsmåte for fremstilling av farmasøytiske preparater NO20040312L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10137515A DE10137515A1 (de) 2001-07-26 2001-07-26 Verfahren zur Herstellung pharmazeutischer Zubereitungen
PCT/EP2002/007863 WO2003011459A1 (de) 2001-07-26 2002-07-15 Verfahren zur hestellung pharmazeutischer zubereitungen

Publications (1)

Publication Number Publication Date
NO20040312L true NO20040312L (no) 2004-01-23

Family

ID=7693878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040312A NO20040312L (no) 2001-07-26 2004-01-23 Fremgangsmåte for fremstilling av farmasøytiske preparater

Country Status (5)

Country Link
EP (1) EP1463583A1 (no)
JP (1) JP2004535907A (no)
DE (1) DE10137515A1 (no)
NO (1) NO20040312L (no)
WO (1) WO2003011459A1 (no)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1116518A (en) * 1977-09-30 1982-01-19 Guido Neri Method for purifying a liposomic suspension
JPS6014984A (ja) * 1983-07-07 1985-01-25 Asahi Chem Ind Co Ltd イオンと微粒子を除去する方法
US4844882A (en) * 1987-12-29 1989-07-04 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent
DK0580878T3 (da) * 1992-06-01 1996-02-12 Basf Ag Anvendelse af dispersioner af magneto-ioniske partikler som MRI-kontrastmedier
WO1995025789A1 (en) * 1994-03-22 1995-09-28 The Immune Response Corporation Highly efficient production and isolation of viral particles
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US5503723A (en) * 1995-02-08 1996-04-02 Eastman Kodak Company Isolation of ultra small particles
DE19624426A1 (de) * 1996-06-19 1998-01-02 Christian Bergemann Magnetische Flüssigkeiten für den Transport von diagnostisch oder therapeutisch wirksamen Substanzen
AU727764B2 (en) * 1996-08-05 2000-12-21 Schering Aktiengesellschaft Process for the production of contrast media for magnetic resonance tomography

Also Published As

Publication number Publication date
DE10137515A1 (de) 2003-02-13
EP1463583A1 (de) 2004-10-06
JP2004535907A (ja) 2004-12-02
WO2003011459A1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20033556D0 (no) Farmasöytiske preparater
NO20041277L (no) Farmasoytiske preparater for behandling av astma.
NO20031692L (no) Fremgangsmåte for fremstilling av pulverformuleringer
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
EE200100259A (et) Moksifloksatsiini farmatseutiline preparaat
EE04747B1 (et) Amiini-plaatina komplekside valmistamismeetod
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
IS7097A (is) Lyfjablanda til að gefa fúlvestrant í vöðva
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
NO20023445D0 (no) Fremgangsmåte for fremstilling av peptider
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
GB0127832D0 (en) Method for the preparation of pharmaceutical nanosuspensions
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
FI20010892A0 (fi) Menetelmä ksylitolin valmistamiseksi
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application